![Benjamin Zeskind](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Benjamin Zeskind
Oprichter bij
IMMUNEERING CORPORATION
Vermogen: 16 M $ op 30-06-2026
Profiel
Benjamin J.
Zeskind is the founder of Immuneering Corp., established in 2008, where the titles held include President, Chief Executive Officer & Director since 2008.
The education history includes a doctorate from the Massachusetts Institute of Technology conferred in 2006 and an MBA from Harvard Business School conferred in 2008.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 23-06-2026 | 3.210.179 ( 4,96% ) | 16 M $ | 30-06-2026 |
Actieve functies van Benjamin Zeskind
| Bedrijven | Functie | Begin |
|---|---|---|
| IMMUNEERING CORPORATION | Oprichter | 01-01-2008 |
Opleiding van Benjamin Zeskind
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
93
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immuneering Corp.
 Immuneering Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, focuses on the oncology and neuroscience product candidates | Health Technology |
Kies MarketScreener 
